Factor XIII deficiency, a rare coagulopathy: case reports

Rare coagulopathies





Deficiência do Fator XIII, Transtornos de Proteínas de Coagulação, Transtornos Herdados da Coagulação Sanguínea, Fator XIII


Introduction: Hereditary Factor XIII (FXIII) deficiency is a rare autosomal recessive hemostatic disorder with an estimated incidence of one case per two million individuals and a higher prevalence in descendants of consanguineous relationships. Possible clinical manifestations include intracranial hemorrhage, umbilical cord bleeding at birth, hematoma, spontaneous abortions, and menometrorrhagia. Objective: To highlight the peculiarities of this hemostatic disorder, as well as the recommended management. Case Report: The authors describe two cases of FXIII deficiency with different hemorrhagic manifestations. Case 1 presented extensive spontaneous hematoma in the right thigh, while Case 2 had umbilical cord bleeding at birth and intracranial hemorrhage, requiring hemotherapy support. Both patients had normal results in screening laboratory tests for coagulation disorders. Coagulation factor serum levels and diagnostic assessments identified mild Factor XIII deficiency in Case 1 and severe deficiency in Case 2. The patient in Case 1 is under regular control and follow-up, while the patient in Case 2 is on a monthly prophylactic regimen with FXIII infusion. Conclusion: The diagnosis of FXIII deficiency in patients with significant bleeding should be considered if screening coagulation tests are normal. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis has established an algorithm for laboratory diagnosis and identification of different forms of FXIII deficiency. Quantitative determination of FXIII activity, antigenic assays, and molecular studies are necessary.


Não há dados estatísticos.


Alshehri FSM, Whyte CS, Mutch NJ. Factor XIII-A: an indispensable "factor" in haemostasis and wound healing. Int J Mol Sci. 2021; 22(6):3055. doi: 10.3390/ijms22063055.

Amano S, Oka K, Sato Y, Sano C, Ohta R. Measuring Factor XIII inhibitors in patients with Factor XIII deficiency: a case report and systematic review of current practices in Japan. J Clin Med. 2022; 11(6):1699. doi: 10.3390/jcm11061699.

Zanon E, Pasca S, Sottilotta G et al. A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice: The Italian FXIII Study. Blood Transfus. 2023; 21(4):350-5. doi: 10.2450/2022.0121-22.

Ministério da Saúde (BR). Secretaria de Atenção Escpecializada à Saúde. Departamento de Atenção Especializada em Temática. Coordenação-Geral de Sangue e Hemoderivados. Sistematização: dados coagulopatias hereditárias 2022 [Internet]. Brasília: Ministério da Saúde; 2022 [accessed in 2024 Jan]. Available at: https://www.gov.br/saude/pt-br/composicao/saes/sangue/publicacoes/coagulopatias/dados-perfil-coagulopatias-hereditarias-brasil-2022.

Ministério da Saúde (BR). Secretaria de Atenção Escpecializada à Saúde. Departamento de Atenção Especializada em Temática. Coordenação-Geral de Sangue e Hemoderivados. Sistematização: dados coagulopatias hereditárias 2021 [Internet]. Brasília: Ministério da Saúde; 2021 [accessed in 2023 Oct]. Available at: https://www.gov.br/saude/pt-br/composicao/saes/sangue/publicacoes/coagulopatias/dados-coagulopatias-2021.pdf.

Ministério da Saúde (BR). Manual das Coagulopatias Raras. Brasília: Ministério da Saúde; 2015.

Yan L, Wang T, Qiu J et al. Identification of a novel mutation in the factor XIII: a subunit in a patient with inherited factor XIII deficiency. Int J Hematol. 2023; 118:26-35. doi: 10.1007/s12185-023-03594-y.

Schroeder V. Laboratory assessment of coagulation Factor XIII. Hamostaseologie. 2020; 40(4):467-71. doi: 10.1055/a-1181-0327.

World Federation of Hemophilia. Report on the annual global survey 2020 is published by the World Federation of Hemophilia. All data are provisional. World Federation of Hemophilia; 2021.

Gusmão AC, Magalhães NNS, Almeida RDM, Santos ACA, Espósito TS et al. Inherited Factor XIII deficiency: a mild and a severe case reports [Internet]. Res Pract Thromb Haemost. 2021 [accessed in 2023 July]; 5(Suppl 2). Available at: https://abstracts.isth.org/abstract/inherited-factor-xiii-deficiency-a-mild-and-a-severe-case-reports/.

Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960; 5:179-86.

Cohen EL, Millikan SE, Morocco PC, de Jong JLO. Hemorrhagic shock after neonatal circumcision: severe congenital Factor XIII Deficiency. Case Rep Pediatr. 2021; 5550199.

Xu PP, Ding BJ, Li MJ, Liu JP, Liu L et al. Hereditary coagulation factor XIII deficiency: three cases report and literature review. Zhonghua Xue Ye Xue Za Zhi. 2021; 42(3):256-8.

Ejaz M, Saleem A, Ali N, Tariq F. Factor XIII deficiency with intracranial haemorrhage. BMJ Case Rep. 2019; 12(8):e228682

Cai R, Li Y, Wang W, Feng Q. A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report. BMC Med Genet. 2020; 21(1):175.

Roberts JC, Javed MJ, Lundy MK, Burns RM, Wang H, Tarantino MD. Characterization of laboratory coagulation parameters and risk factors for intraventricular hemorrhage in extremely premature neonates. J Thromb Haemost. 2022; 20:1797-807.

Ministério da Saúde (BR). Web coagulopatias: 2023 [Internet]. Brasília: Ministério da Saúde; 2023 [accessed in 2024 Jan]. Avaible at: http://coagulopatiasweb.datasus.gov.br/index.php.




Como Citar

de Oliveira Werneck Rodrigues D, Boa Sorte Costa I, de Paula Silva Souza S, do Carmo Gusmão A. Factor XIII deficiency, a rare coagulopathy: case reports: Rare coagulopathies. HU Rev [Internet]. 22º de janeiro de 2024 [citado 21º de abril de 2024];49:1-6. Disponível em: https://periodicos.ufjf.br/index.php/hurevista/article/view/43058



Relato de Caso

Artigos mais lidos pelo mesmo(s) autor(es)